ZS Ph2/3 Dose-response Study in Japan

NCT03127644 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperkalemia

Interventions

DRUG: Sodium Zirconium Cyclosilicate (ZS) 5g
DRUG: Sodium Zirconium Cyclosilicate (ZS) 10g
DRUG: Placebo

Sponsor

AstraZeneca